Summit Therapeutics (SMMT) Deferred Taxes (2019 - 2020)
Summit Therapeutics (SMMT) posted quarterly Deferred Taxes of -$99000.0 for Q4 2020, down 182.5% year-on-year from $120000.0 in Q1 2020, and down 182.5% on a QoQ basis from $120000.0 in Q4 2019.
Summit Therapeutics (SMMT) Deferred Taxes (2019 - 2020) Analysis & Trends
Summit Therapeutics (SMMT) has reported Deferred Taxes for 2 consecutive years, with -$99000.0 the latest figure, recorded in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Summit Therapeutics | 11.62 Bn | 11.03 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -99,000.00 |
| Dec 31, 2019 | 120,000.00 |